JPRN-C000000240Completed未知
A multi-center trial of combination therapy of hormonal therapy and Green Tea Extract (GTE) in stage C,D prostate cancer patients - A trial of combination therapy of hormonal therapy and Green Tea Extract (GTE) in prostate cancer patients
The University of Tsukuba Graduate Schools0 sites200 target enrollmentStarted: September 20, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a) Patients who have active double cancer. b) Patients who have digestive tract ulcer and a critical liver, kidney, and heart disease. c) Patients who experienced palpitation and heartburn with coffee or tea. d) Patients who have abnormality in a blood cells or biochemical examination of blood classified into two or more grade of NCI toxicity criteria e) Patients considered not to have a six months prognosis. f) Patients who are judged to be unsuitable for the study.
Investigators
Similar Trials
Completed
Not Applicable
Multicentric study of combination therapy of theophylline and tiotropium in COPDChronic obstructive pulmonary disease (COPD)JPRN-C000000367Graduate school of biomedical sciences, Hiroshima university, department of molecular and internal medicine100
Not yet recruiting
Unknown
Study on Vitamin C , Thiamine and Hydrocortisone in Septic shock patientsCTRI/2024/07/070812Dasari Sai Divya
Active, not recruiting
Phase 1
Multicentric trial on the use of combined therapy of Thiamine and biotine in patients with Huntington´s disease.Huntington´s disease.MedDRA version: 20.0Level: PTClassification code: 10070668Term: Huntington's disease Class: 100000004850CTIS2023-508637-14-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla24
Unknown
Phase 3
Clinical investigation for combination therapy of KAD-1229 and Pioglitazone.Type 2 diabetesJPRN-jRCT2080220136KISSEI PHARMACEUTICAL CO.,LTD.
Recruiting
Not Applicable
Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trialJPRN-UMIN000032193Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine40